Literature DB >> 2398150

Intradural spinal metastases in pediatric patients with primary intracranial neoplasms: Gd-DTPA enhanced MR vs CT myelography.

D E Blews1, H Wang, A J Kumar, P A Robb, P C Phillips, R N Bryan.   

Abstract

Recently, the application of intravenous gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) has been shown to improve the detection of intradural extramedullary spinal disease in adults. The ability of Gd-DTPA enhanced magnetic resonance (MR) to detect intradural extramedullary spinal metastases was studied in pediatric brain tumor patients. Spinal MR images before and after intravenous injection of Gd-DTPA were analyzed retrospectively in eight pediatric patients with known intracranial neoplasms and clinically suspected subarachnoid tumor seedings. Contrast enhanced spinal MR was compared with CT myelography in four of these patients. In our pediatric population Gd-DTPA enhanced images revealed tumor seeding not appreciable on noncontrast images. Although CT myelography has been the accepted standard investigation in the evaluation of suspected spinal metastases in children, we found that contrast enhanced MR is equal or superior in sensitivity to CT myelography. Spinal MR also provided information not obtainable via CT myelography. In the future, Gd-DTPA enhanced spinal MR should be considered in the initial evaluation of suspected subarachnoid spinal metastases in pediatric patients with known primary brain tumors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2398150     DOI: 10.1097/00004728-199009000-00009

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

Review 1.  Myelopathy.

Authors:  D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-05       Impact factor: 3.825

2.  Results of sequential chemoradiotherapy for intracranial germinoma.

Authors:  Masahiro Kenjo; Fumiyuki Yamasaki; Takeshi Takayasu; Ryo Nosaka; Yuji Murakami; Tomoki Kimura; Yoshiko Doi; Tomoyuki Okabe; Kazuhiko Sugiyama; Yasushi Nagata
Journal:  Jpn J Radiol       Date:  2015-05-06       Impact factor: 2.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.